680 Crystallization of Pharmaceutical and Biological Molecules

Thursday, November 20, 2014: 12:30 PM
301 (Hilton Atlanta)
Description:
This session welcomes papers addressing fundamental as well as applied studies in the area of crystallization of pharmaceutical or biological molecules. Topics related to experimental studies, theory and simulation that contribute to fundamental understanding of crystallization as well as industrial case studies on the crystallization development of pharmaceutical and biological compounds are encouraged.

Sponsor:
Crystallization and Evaporation
Co-Sponsor(s):
Pharmaceuticals (15B), Pharmaceutical Discovery, Development and Manufacturing Forum (26)

Chair:
Sarah L. Perry
Email: perrys@engin.umass.edu

Co-Chair:
Fang Wang
Email: fang.wang@gilead.com


12:30 PM
Break

12:55 PM
(680b) Influence of Controlled Fluid Shear on Nucleation Kinetics in Glycine Aqueous Solutions
Carol Forsyth, Paul Mulheran, Claire Forsyth and Jan Sefcik

1:17 PM
(680c) Analysis of Crystallization Kinetics Based on CSD Estimates from PAT Tools
Huayu Li, Ronald W. Rousseau, Yoshiaki Kawajiri and Martha Grover

1:39 PM
(680f) Heterogeneous Nucleation of APIs on Engineered Biocompatible Polymer Surfaces
Li Tan, Rachel M. Davis, Allan S. Myerson and Bernhardt L. Trout

2:01 PM
(680e) Impact of Surface Chemistry on Crystallization of Acetaminophen
Hsin-Yun Hsu, M T Harris and Lynne Taylor

2:23 PM
(680d) Development of a Robust API Crystallization in a Multi-Component Solvent Mixture: Using High Throughput Automation As an Enabling Technology to Develop Comprehensive Solubility Maps
Benjamin Cohen, Michelle Mahoney, Brenda Remy, Jun Qiu, Chris Sfouggatakis, Zhongping Shi and Chenchi Wang
See more of this Group/Topical: Separations Division
<< Previous Session | Next Session >>